Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study.
van Gils MJ, Lavell A, van der Straten K, Appelman B, Bontjer I, Poniman M, Burger JA, Oomen M, Bouhuijs JH, van Vught LA, Slim MA, Schinkel M, Wynberg E, van Willigen HDG, Grobben M, Tejjani K, van Rijswijk J, Snitselaar JL, Caniels TG; Amsterdam UMC COVID-19 S3/HCW study group; Vlaar APJ, Prins M, de Jong MD, de Bree GJ, Sikkens JJ, Bomers MK, Sanders RW. van Gils MJ, et al. Among authors: van vught la, van willigen hdg, van der straten k, van rijswijk j. PLoS Med. 2022 May 17;19(5):e1003991. doi: 10.1371/journal.pmed.1003991. eCollection 2022 May. PLoS Med. 2022. PMID: 35580156 Free PMC article.
Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination.
Caniels TG, Bontjer I, van der Straten K, Poniman M, Burger JA, Appelman B, Lavell AHA, Oomen M, Godeke GJ, Valle C, Mögling R, van Willigen HDG, Wynberg E, Schinkel M, van Vught LA, Guerra D, Snitselaar JL, Chaturbhuj DN, Cuella Martin I; Amsterdam UMC COVID-19 S3/HCW study group; Moore JP, de Jong MD, Reusken C, Sikkens JJ, Bomers MK, de Bree GJ, van Gils MJ, Eggink D, Sanders RW. Caniels TG, et al. Among authors: van vught la, van gils mj, van willigen hdg, van der straten k. Sci Adv. 2021 Sep 3;7(36):eabj5365. doi: 10.1126/sciadv.abj5365. Epub 2021 Sep 3. Sci Adv. 2021. PMID: 34516917 Free PMC article.
Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination.
Appelman B, van der Straten K, Lavell AHA, Schinkel M, Slim MA, Poniman M, Burger JA, Oomen M, Tejjani K, Vlaar APJ, Wiersinga WJ, Smulders YM, van Vught LA, Sanders RW, van Gils MJ, Bomers MK, Sikkens JJ; Amsterdam UMC COVID-19 S3/HCW study group. Appelman B, et al. Among authors: van vught la, van gils mj, van der straten k. EBioMedicine. 2021 Oct;72:103589. doi: 10.1016/j.ebiom.2021.103589. Epub 2021 Sep 24. EBioMedicine. 2021. PMID: 34571363 Free PMC article.
Inflammatory biomarkers at hospital discharge are associated with readmission and death in patients hospitalized for COVID-19.
Slim MA, Appelman B, Müller MCA, Brouwer MC, Vlaar APJ, Wiersinga WJ, van Vught LA; Amsterdam UMC COVID-19 biobank study group. Slim MA, et al. Among authors: van vught la. Eur J Clin Microbiol Infect Dis. 2021 Dec;40(12):2677-2683. doi: 10.1007/s10096-021-04355-7. Epub 2021 Oct 28. Eur J Clin Microbiol Infect Dis. 2021. PMID: 34713349 Free PMC article. No abstract available.
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination.
Grobben M, van der Straten K, Brouwer PJ, Brinkkemper M, Maisonnasse P, Dereuddre-Bosquet N, Appelman B, Lavell AA, van Vught LA, Burger JA, Poniman M, Oomen M, Eggink D, Bijl TP, van Willigen HD, Wynberg E, Verkaik BJ, Figaroa OJ, de Vries PJ, Boertien TM; Amsterdam UMC COVID-19 S3/HCW study group; Bomers MK, Sikkens JJ, Le Grand R, de Jong MD, Prins M, Chung AW, de Bree GJ, Sanders RW, van Gils MJ. Grobben M, et al. Among authors: van vught la, van gils mj, van willigen hd, van der straten k. Elife. 2021 Nov 23;10:e70330. doi: 10.7554/eLife.70330. Elife. 2021. PMID: 34812143 Free PMC article.
Indoleamine 2,3-dioxygenase (IDO)-1 and IDO-2 activity and severe course of COVID-19.
Guo L, Schurink B, Roos E, Nossent EJ, Duitman JW, Vlaar AP, van der Valk P, Vaz FM, Yeh SR, Geeraerts Z, Dijkhuis A, van Vught L, Bugiani M, Lutter R; also on behalf of the Amsterdam UMC COVID-19 Biobank Study Group. Guo L, et al. J Pathol. 2022 Mar;256(3):256-261. doi: 10.1002/path.5842. Epub 2022 Jan 10. J Pathol. 2022. PMID: 34859884 Free PMC article.
SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June-October 2020.
Coyer L, Boyd A, Schinkel J, Agyemang C, Galenkamp H, Koopman ADM, Leenstra T, Moll van Charante EP, van den Born BH, Lok A, Verhoeff A, Zwinderman AH, Jurriaans S, van Vught LA, Stronks K, Prins M. Coyer L, et al. Among authors: van vught la, van den born bh. BMJ Open. 2022 Jan 6;12(1):e052752. doi: 10.1136/bmjopen-2021-052752. BMJ Open. 2022. PMID: 34992110 Free PMC article.
A single mRNA vaccine dose in COVID-19 patients boosts neutralizing antibodies against SARS-CoV-2 and variants of concern.
van Gils MJ, van Willigen HDG, Wynberg E, Han AX, van der Straten K, Burger JA, Poniman M, Oomen M, Tejjani K, Bouhuijs JH, Verveen A, Lebbink R, Dijkstra M, Appelman B, Lavell AHA, Caniels TG, Bontjer I, van Vught LA, Vlaar APJ, Sikkens JJ, Bomers MK, Russell CA, Kootstra NA, Sanders RW, Prins M, de Bree GJ, de Jong MD; RECoVERED Study Group. van Gils MJ, et al. Among authors: van vught la, van willigen hdg, van der straten k. Cell Rep Med. 2021 Dec 14;3(1):100486. doi: 10.1016/j.xcrm.2021.100486. eCollection 2022 Jan 18. Cell Rep Med. 2021. PMID: 35103254 Free PMC article.
Personalised immunotherapy in sepsis: a scoping review protocol.
Slim MA, van Mourik N, Dionne JC, Oczkowski SJW, Netea MG, Pickkers P, Giamarellos-Bourboulis EJ, Müller MCA, van der Poll T, Wiersinga WJ, Vlaar APJ, van Vught LA. Slim MA, et al. Among authors: van vught la, van mourik n, van der poll t. BMJ Open. 2022 May 9;12(5):e060411. doi: 10.1136/bmjopen-2021-060411. BMJ Open. 2022. PMID: 35534059 Free PMC article.
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Vlaar APJ, Witzenrath M, van Paassen P, Heunks LMA, Mourvillier B, de Bruin S, Lim EHT, Brouwer MC, Tuinman PR, Saraiva JFK, Marx G, Lobo SM, Boldo R, Simon-Campos JA, Cornet AD, Grebenyuk A, Engelbrecht JM, Mukansi M, Jorens PG, Zerbib R, Rückinger S, Pilz K, Guo R, van de Beek D, Riedemann NC; PANAMO study group. Vlaar APJ, et al. Lancet Respir Med. 2022 Dec;10(12):1137-1146. doi: 10.1016/S2213-2600(22)00297-1. Epub 2022 Sep 7. Lancet Respir Med. 2022. PMID: 36087611 Free PMC article. Clinical Trial.
116 results